ID   TINAG_HUMAN             Reviewed;         476 AA.
AC   Q9UJW2; Q5T467; Q9UJW1; Q9ULZ4;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   28-JUN-2023, entry version 177.
DE   RecName: Full=Tubulointerstitial nephritis antigen;
DE            Short=TIN-Ag;
GN   Name=TINAG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAF08931.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANT
RP   PRO-158.
RC   TISSUE=Kidney {ECO:0000269|PubMed:10652240};
RX   PubMed=10652240; DOI=10.1006/bbrc.2000.2103;
RA   Ikeda M., Takemura T., Hino S., Yoshioka K.;
RT   "Molecular cloning, expression, and chromosomal localization of a human
RT   tubulointerstitial nephritis antigen.";
RL   Biochem. Biophys. Res. Commun. 268:225-230(2000).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND VARIANT PRO-158.
RC   TISSUE=Kidney {ECO:0000269|PubMed:10752525};
RX   PubMed=10752525; DOI=10.1681/asn.v114658;
RA   Zhou B., Nelson T.R., Kashtan C., Gleason B., Michael A.F., Vlassi M.,
RA   Charonis A.S.;
RT   "Identification of two alternatively spliced forms of human
RT   tubulointerstitial nephritis antigen (TIN-Ag).";
RL   J. Am. Soc. Nephrol. 11:658-668(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   IDENTIFICATION, AND INVOLVEMENT IN TUBULOINTERSTITIAL NEPHRITIS.
RC   TISSUE=Kidney {ECO:0000269|PubMed:3553704};
RX   PubMed=3553704; DOI=10.1038/ki.1987.69;
RA   Fliger F.D., Wieslander J., Brentjens J.R., Andres G.A., Butkowski R.J.;
RT   "Identification of a target antigen in human anti-tubular basement membrane
RT   nephritis.";
RL   Kidney Int. 31:800-807(1987).
RN   [7] {ECO:0000305}
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=1762287; DOI=10.1038/ki.1991.283;
RA   Butkowski R.J., Kleppel M.M., Katz A., Michael A.F., Fish A.J.;
RT   "Distribution of tubulointerstitial nephritis antigen and evidence for
RT   multiple forms.";
RL   Kidney Int. 40:838-846(1991).
RN   [8] {ECO:0000305}
RP   DISEASE.
RX   PubMed=1466368; DOI=10.1016/0002-9343(92)90205-p;
RA   Katz A., Fish A.J., Santamaria P., Nevins T.E., Kim Y., Butkowski R.J.;
RT   "Role of antibodies to tubulointerstitial nephritis antigen in human anti-
RT   tubular basement membrane nephritis associated with membranous
RT   nephropathy.";
RL   Am. J. Med. 93:691-698(1992).
RN   [9] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=8770961; DOI=10.1038/ki.1996.20;
RA   Chen Y., Krishnamurti U., Wayner E.A., Michael A.F., Charonis A.S.;
RT   "Receptors in proximal tubular epithelial cells for tubulointerstitial
RT   nephritis antigen.";
RL   Kidney Int. 49:153-157(1996).
RN   [10] {ECO:0000305}
RP   DEVELOPMENTAL STAGE.
RX   PubMed=9643646; DOI=10.3109/03008209809028899;
RA   Nelson T.R., Kim Y., Michael A.F., Butkowski R.J., Charonis A.S.;
RT   "Tubulointerstitial nephritis antigen (TIN-ag) is expressed in distinct
RT   segments of the developing human nephron.";
RL   Connect. Tissue Res. 37:53-60(1998).
CC   -!- FUNCTION: Mediates adhesion of proximal tubule epithelial cells via
CC       integrins alpha3-beta1 and alphaV-beta3. This is a non catalytic
CC       peptidase C1 family protein. {ECO:0000269|PubMed:8770961}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix, basement membrane {ECO:0000269|PubMed:10752525,
CC       ECO:0000269|PubMed:1762287}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=TIN1 {ECO:0000269|PubMed:10752525};
CC         IsoId=Q9UJW2-1; Sequence=Displayed;
CC       Name=2; Synonyms=TIN2 {ECO:0000269|PubMed:10752525};
CC         IsoId=Q9UJW2-2; Sequence=VSP_050567, VSP_050568;
CC   -!- TISSUE SPECIFICITY: Expressed in the kidney cortex, small intestine and
CC       cornea. {ECO:0000269|PubMed:10652240, ECO:0000269|PubMed:10752525,
CC       ECO:0000269|PubMed:1762287}.
CC   -!- DEVELOPMENTAL STAGE: Initially observed in the Bowman capsule during
CC       early glomerular capillary loop formation in the kidney. In more
CC       developmentally mature glomeruli, following transition from early to
CC       mid-capillary loop stage, expression is higher in the proximal tubular
CC       basement membrane than in the distal basement membrane and Bowman
CC       capsule. {ECO:0000269|PubMed:9643646}.
CC   -!- PTM: It has been suggested that the active SMB domain may be permitted
CC       considerable disulfide bond heterogeneity or variability, thus 2
CC       alternate disulfide patterns based on 3D structures are described with
CC       1 disulfide bond conserved in both.
CC   -!- MISCELLANEOUS: Antibodies against TINAG are found in sera of patients
CC       with tubulointerstitial nephritis, a rare autoimmune disorder that
CC       causes acute and chronic renal injury.
CC   -!- MISCELLANEOUS: [Isoform 1]: Major isoform.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU10090}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB022277; BAA84949.1; -; mRNA.
DR   EMBL; AF195116; AAF08931.1; -; mRNA.
DR   EMBL; AF195117; AAF08932.1; -; mRNA.
DR   EMBL; AK312918; BAG35763.1; -; mRNA.
DR   EMBL; AL359380; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL589946; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04437.1; -; Genomic_DNA.
DR   CCDS; CCDS4955.1; -. [Q9UJW2-1]
DR   PIR; JC7189; JC7189.
DR   RefSeq; NP_055279.3; NM_014464.3. [Q9UJW2-1]
DR   AlphaFoldDB; Q9UJW2; -.
DR   SMR; Q9UJW2; -.
DR   BioGRID; 118107; 75.
DR   IntAct; Q9UJW2; 24.
DR   STRING; 9606.ENSP00000259782; -.
DR   MEROPS; C01.973; -.
DR   GlyCosmos; Q9UJW2; 6 sites, 2 glycans.
DR   GlyGen; Q9UJW2; 6 sites, 2 O-linked glycans (1 site).
DR   iPTMnet; Q9UJW2; -.
DR   PhosphoSitePlus; Q9UJW2; -.
DR   BioMuta; TINAG; -.
DR   DMDM; 317373501; -.
DR   EPD; Q9UJW2; -.
DR   jPOST; Q9UJW2; -.
DR   MassIVE; Q9UJW2; -.
DR   PaxDb; Q9UJW2; -.
DR   PeptideAtlas; Q9UJW2; -.
DR   ProteomicsDB; 84670; -. [Q9UJW2-1]
DR   ProteomicsDB; 84671; -. [Q9UJW2-2]
DR   ABCD; Q9UJW2; 4 sequenced antibodies.
DR   Antibodypedia; 31018; 89 antibodies from 21 providers.
DR   DNASU; 27283; -.
DR   Ensembl; ENST00000259782.9; ENSP00000259782.4; ENSG00000137251.16. [Q9UJW2-1]
DR   GeneID; 27283; -.
DR   KEGG; hsa:27283; -.
DR   MANE-Select; ENST00000259782.9; ENSP00000259782.4; NM_014464.4; NP_055279.3.
DR   UCSC; uc003pcj.3; human. [Q9UJW2-1]
DR   AGR; HGNC:14599; -.
DR   CTD; 27283; -.
DR   DisGeNET; 27283; -.
DR   GeneCards; TINAG; -.
DR   HGNC; HGNC:14599; TINAG.
DR   HPA; ENSG00000137251; Tissue enriched (kidney).
DR   MIM; 606749; gene.
DR   neXtProt; NX_Q9UJW2; -.
DR   OpenTargets; ENSG00000137251; -.
DR   PharmGKB; PA37905; -.
DR   VEuPathDB; HostDB:ENSG00000137251; -.
DR   eggNOG; KOG1544; Eukaryota.
DR   GeneTree; ENSGT00940000161065; -.
DR   HOGENOM; CLU_012184_3_2_1; -.
DR   InParanoid; Q9UJW2; -.
DR   OMA; HTNGPCP; -.
DR   OrthoDB; 808912at2759; -.
DR   PhylomeDB; Q9UJW2; -.
DR   TreeFam; TF313765; -.
DR   PathwayCommons; Q9UJW2; -.
DR   SignaLink; Q9UJW2; -.
DR   BioGRID-ORCS; 27283; 16 hits in 1146 CRISPR screens.
DR   GeneWiki; TINAG; -.
DR   GenomeRNAi; 27283; -.
DR   Pharos; Q9UJW2; Tbio.
DR   PRO; PR:Q9UJW2; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9UJW2; protein.
DR   Bgee; ENSG00000137251; Expressed in kidney epithelium and 52 other tissues.
DR   ExpressionAtlas; Q9UJW2; baseline and differential.
DR   Genevisible; Q9UJW2; HS.
DR   GO; GO:0005604; C:basement membrane; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc.
DR   GO; GO:0000166; F:nucleotide binding; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:InterPro.
DR   CDD; cd02620; Peptidase_C1A_CathepsinB; 1.
DR   Gene3D; 3.90.70.10; Cysteine proteinases; 1.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR001212; Somatomedin_B_dom.
DR   PANTHER; PTHR12411; CYSTEINE PROTEASE FAMILY C1-RELATED; 1.
DR   PANTHER; PTHR12411:SF274; TUBULOINTERSTITIAL NEPHRITIS ANTIGEN; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   Pfam; PF01033; Somatomedin_B; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   SMART; SM00201; SO; 1.
DR   SUPFAM; SSF54001; Cysteine proteinases; 1.
DR   PROSITE; PS00524; SMB_1; 1.
DR   PROSITE; PS50958; SMB_2; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Basement membrane; Cell adhesion; Disulfide bond;
KW   Extracellular matrix; Glycoprotein; Reference proteome; Secreted.
FT   CHAIN           1..476
FT                   /note="Tubulointerstitial nephritis antigen"
FT                   /id="PRO_0000050600"
FT   DOMAIN          59..107
FT                   /note="SMB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   SITE            49..50
FT                   /note="Cleavage; by furin"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        38
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        175
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        314
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        360
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        455
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        63..70
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        70..102
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        81..95
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        81..83
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        87..94
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DISULFID        95..102
FT                   /note="Alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   VAR_SEQ         119..169
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10752525"
FT                   /id="VSP_050567"
FT   VAR_SEQ         209..300
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10752525"
FT                   /id="VSP_050568"
FT   VARIANT         3
FT                   /note="T -> A (in dbSNP:rs16885197)"
FT                   /id="VAR_047091"
FT   VARIANT         22
FT                   /note="Q -> R (in dbSNP:rs2297980)"
FT                   /id="VAR_047092"
FT   VARIANT         158
FT                   /note="S -> P (in dbSNP:rs1058768)"
FT                   /evidence="ECO:0000269|PubMed:10652240,
FT                   ECO:0000269|PubMed:10752525"
FT                   /id="VAR_047093"
FT   VARIANT         413
FT                   /note="V -> I (in dbSNP:rs34011963)"
FT                   /id="VAR_047094"
FT   VARIANT         433
FT                   /note="I -> L (in dbSNP:rs3736352)"
FT                   /id="VAR_047095"
FT   CONFLICT        7..8
FT                   /note="IL -> FS (in Ref. 2; AAF08931/AAF08932)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        175
FT                   /note="N -> I (in Ref. 2; AAF08932)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="P -> L (in Ref. 1; BAA84949)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        333
FT                   /note="H -> D (in Ref. 2; AAF08931/AAF08932)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        381
FT                   /note="R -> H (in Ref. 1; BAA84949)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        421
FT                   /note="L -> R (in Ref. 2; AAF08932)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        437
FT                   /note="S -> F (in Ref. 2; AAF08931/AAF08932)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        463
FT                   /note="I -> V (in Ref. 2; AAF08931/AAF08932)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   476 AA;  54605 MW;  6D90C734DAC3A5AE CRC64;
     MWTGYKILIF SYLTTEIWME KQYLSQREVD LEAYFTRNHT VLQGTRFKRA IFQGQYCRNF
     GCCEDRDDGC VTEFYAANAL CYCDKFCDRE NSDCCPDYKS FCREEKEWPP HTQPWYPEGC
     FKDGQHYEEG SVIKENCNSC TCSGQQWKCS QHVCLVRSEL IEQVNKGDYG WTAQNYSQFW
     GMTLEDGFKF RLGTLPPSPM LLSMNEMTAS LPATTDLPEF FVASYKWPGW THGPLDQKNC
     AASWAFSTAS VAADRIAIQS KGRYTANLSP QNLISCCAKN RHGCNSGSID RAWWYLRKRG
     LVSHACYPLF KDQNATNNGC AMASRSDGRG KRHATKPCPN NVEKSNRIYQ CSPPYRVSSN
     ETEIMKEIMQ NGPVQAIMQV REDFFHYKTG IYRHVTSTNK ESEKYRKLQT HAVKLTGWGT
     LRGAQGQKEK FWIAANSWGK SWGENGYFRI LRGVNESDIE KLIIAAWGQL TSSDEP
//
